Published in Ultrasound Obstet Gynecol on May 01, 1998
Comparison of transvaginal sonography and saline contrast sonohysterography in women with abnormal uterine bleeding: correlation with hysteroscopy and histopathology. Int J Health Sci (Qassim) (2007) 0.83
To Evaluate the Accuracy of Saline Infusion Sonohysterography (SIS) for Evaluation of Uterine Cavity Abnormalities in Patients with Abnormal Uterine Bleeding. J Obstet Gynaecol India (2014) 0.81
Effectiveness of transcervical hysteroscopic endometrial resection based on the prevention of the recurrence of endometrial polyps in post-menopausal women. BMC Womens Health (2015) 0.75
Evaluation of sonohysterography in detecting endometrial polyps - 241 cases followed with office hysteroscopies combined with histopathological examination. Wideochir Inne Tech Maloinwazyjne (2014) 0.75
Three-dimensional sonohysterography for examination of the uterine cavity in women with abnormal uterine bleeding: Preliminary findings. J Ultrasound (2009) 0.75
Submucosal uterine fibroid prolapsed into vagina in a symptomatic patient with IUS. BMJ Case Rep (2014) 0.75
Hysteroscopy in evaluation of abnormal uterine bleeding. J Obstet Gynaecol India (2011) 0.75
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet (1994) 4.03
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Systemic absorption of progesterone from Progest cream in postmenopausal women. Lancet (1998) 2.78
Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol (2000) 2.70
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
Transabdominal ultrasound screening for early ovarian cancer. BMJ (1989) 2.20
Ultrasound screening for familial ovarian cancer. Gynecol Oncol (1991) 2.19
Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ (1993) 1.98
Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. BMJ (1989) 1.96
Hormonal profiles in postmenopausal women after therapy with subcutaneous implants. Br J Obstet Gynaecol (1981) 1.95
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia (2006) 1.87
Radioimmunoassay of prostaglandin F-2-alpha in peripheral venous plasma from men and women. Prostaglandins (1974) 1.71
A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol (1994) 1.69
Hysterectomy, hormones, and behaviour. A prospective study. Lancet (1981) 1.63
Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod (1993) 1.58
Hormonal profiles after the menopause. Br Med J (1976) 1.58
Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening. Lancet (2000) 1.53
Ovulation side and occurrence of mittelschmerz in spontaneous and induced ovarian cycles. Br Med J (Clin Res Ed) (1982) 1.53
Absorption and metabolism of oral progesterone. Br Med J (1980) 1.52
Radioimmunoassay of plasma testosterone. J Steroid Biochem (1972) 1.48
Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril (1992) 1.45
Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. Ultrasound Obstet Gynecol (1997) 1.43
The role of trophoblast dysfunction in the aetiology of miscarriage. Br J Obstet Gynaecol (1993) 1.40
Transvaginal ultrasound-guided ovarian endoscopy: a novel approach to the assessment of ovarian tumors. Ultrasound Obstet Gynecol (1994) 1.39
Intrafollicular blood flow during human ovulation. Ultrasound Obstet Gynecol (1991) 1.38
Radioimmunoassay of oestrone and oestradiol in human plasma. Acta Endocrinol (Copenh) (1972) 1.37
Ultrasound scanning of ovaries to detect ovulation in women. Fertil Steril (1980) 1.33
Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience. Ultrasound Obstet Gynecol (1999) 1.32
Effects of subcutaneous oestradiol implants on ovarian activity. Br J Obstet Gynaecol (1987) 1.32
Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause. Br Med J (1979) 1.26
Endocrine changes and symptomatology after oophorectomy in premenopausal women. Br J Obstet Gynaecol (1977) 1.26
The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril (1992) 1.26
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet (1999) 1.24
Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum Reprod (1990) 1.23
Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet Gynecol (1994) 1.22
The conservative management of first trimester miscarriages and the use of colour Doppler sonography for patient selection. Hum Reprod (1999) 1.21
Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses. Ultrasound Obstet Gynecol (1999) 1.19
Weight change and cancer risk in a cohort of more than 65,000 adults in Austria. Ann Oncol (2007) 1.17
Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J (1972) 1.17
The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer. Gynecol Oncol (1994) 1.14
Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst (1994) 1.13
A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol (1998) 1.10
Studies on steroid metabolism in human endometrial tissue. Biochem J (1969) 1.10
Genetic epidemiology of ovarian cancer: segregation analysis. Ann Hum Genet (1991) 1.10
Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol (1976) 1.09
[Cost effective media in vaginal ultrasound uterus and fallopian tube diagnosis]. Ultraschall Med (1997) 1.07
Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and colour flow imaging. BMJ (1990) 1.07
Dose-related changes in vaginal cytology after topical conjugated equine oestrogens. Br Med J (Clin Res Ed) (1982) 1.05
A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model. Am J Obstet Gynecol (1999) 1.04
Hysterosalpingo contrast sonography (HyCoSy) and its future role within the investigation of infertility in Europe. Ultrasound Obstet Gynecol (1994) 1.00
The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol (2007) 1.00
Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: a preliminary report. Gynecol Oncol (1991) 0.98
The evaluation of a gas-liquid chromatographic method for the determination of plasms testosterone using nickel-63 electron capture detection. J Chromatogr (1968) 0.98
Transvaginal color blood flow imaging of the periovulatory follicle. Fertil Steril (1993) 0.97
The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function. Acta Endocrinol (Copenh) (1979) 0.96
Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer (2009) 0.96
Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst (1993) 0.95
Radioimmunoassay of plasma testosterone without chromatography: a comparison of four antisera, and the evaluation of a novel approach to liquid scintillation counting. Steroids (1973) 0.94
Ovarian size in postmenopausal women. Br J Obstet Gynaecol (1988) 0.94
Ultrasound derived indices of follicular blood flow before HCG administration and the prediction of oocyte recovery and preimplantation embryo quality. Hum Reprod (1996) 0.93
Formation and metabolism of testosterone in rat skin. Endocrinology (1970) 0.92
Radioimmunoassay of 17-hydroxyprogesterone. Steroids (1972) 0.92
Testosterone levels in midtrimester maternal and fetal plasma and amniotic fluid. Prenat Diagn (1985) 0.92
Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study. Ann Oncol (2009) 0.91
Further studies on radioimmunoassay systems for plasma oestradiol. J Steroid Biochem (1975) 0.91
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). Br J Dermatol (2012) 0.91
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer (1998) 0.91
Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Pathol (1998) 0.90
Secular trends in cardiovascular risk factors: an age-period cohort analysis of 698,954 health examinations in 181,350 Austrian men and women. J Intern Med (2007) 0.90
Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study. Ultrasound Obstet Gynecol (2003) 0.89
Preovulatory changes of blood flow in different regions of the human follicle. Fertil Steril (1998) 0.88
Recent trends and sociodemographic distribution of cardiovascular risk factors: results from two population surveys in the Austrian WHO CINDI demonstration area. Wien Klin Wochenschr (2001) 0.88
Effect of synthetic luteinizing hormone releasing hormone (LH/FSH-RH) in women with menstrual disorders. Br Med J (1972) 0.87
Interactions between the embryo and corpus luteum. Hum Reprod (1993) 0.87
Potent inhibitory effects of steroids in an in vitro model of angiogenesis. J Endocrinol (1996) 0.87
Whole chromosome 17 loss in ovarian cancer. Genes Chromosomes Cancer (1993) 0.87
Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins. J Steroid Biochem (1980) 0.86
Idications for testicular biopsy or exploration in azoospermia. Br J Urol (1978) 0.86
Plasma prostanoids in pregnancy-induced hypertension. Br J Obstet Gynaecol (1982) 0.85
Sonographic prediction of malignancy in adnexal masses using an artificial neural network. Br J Obstet Gynaecol (1999) 0.85
Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol (2002) 0.85
Plasma hormone profiles after the menopause and bilateral oöphorectomy. Postgrad Med J (1978) 0.84
Novel screening strategies for early ovarian cancer by transabdominal ultrasonography. Br J Obstet Gynaecol (1990) 0.84
Oocytic meiosis in cultured rat follicles during inhibition of steroidogenesis. Acta Endocrinol (Copenh) (1976) 0.84
Screening for early ovarian cancer. Br J Hosp Med (1992) 0.84